Laddar...
Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir
AIM: To examine the efficacy of telbivudine (LdT) + adefovir (ADV) vs continuation of lamivudine (LAM) + ADV in patients with LAM-resistant chronic hepatitis B (CHB) who show a suboptimal response to LAM + ADV. METHODS: This was a randomized, active-control, open-label, single-center, parallel trial...
Sparad:
| Huvudupphovsmän: | , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Baishideng Publishing Group Co., Limited
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3837266/ https://ncbi.nlm.nih.gov/pubmed/24431895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i43.7671 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|